Show simple item record

5-HT obesity medication efficacy via POMC activation is maintained during aging

dc.contributor.authorBurke, Luke K
dc.contributor.authorDoslikova, Barbora
dc.contributor.authorD'Agostino, Giuseppe
dc.contributor.authorGarfield, Alastair S
dc.contributor.authorFarooq, Gala
dc.contributor.authorBurdakov, Denis
dc.contributor.authorLow, Malcolm
dc.contributor.authorRubinstein, Marcelo
dc.contributor.authorEvans, Mark L
dc.contributor.authorBillups, Brian
dc.contributor.authorHeisler, Lora
dc.date.accessioned2014-12-10T09:50:01Z
dc.date.available2014-12-10T09:50:01Z
dc.date.issued2014-07-22
dc.identifier40713994
dc.identifier457d5586-233e-4b48-952a-148c23f32d41
dc.identifier25051442
dc.identifier84907222919
dc.identifier.citationBurke , L K , Doslikova , B , D'Agostino , G , Garfield , A S , Farooq , G , Burdakov , D , Low , M , Rubinstein , M , Evans , M L , Billups , B & Heisler , L 2014 , ' 5-HT obesity medication efficacy via POMC activation is maintained during aging ' , Endocrinology , vol. 155 , no. 10 , pp. 3732–3738 . https://doi.org/10.1210/en.2014-1223en
dc.identifier.issn0013-7227
dc.identifier.otherORCID: /0000-0002-7731-1419/work/30894570
dc.identifier.urihttp://hdl.handle.net/2164/4096
dc.format.extent7
dc.format.extent704387
dc.language.isoeng
dc.relation.ispartofEndocrinologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectQP Physiologyen
dc.subject.lccQPen
dc.title5-HT obesity medication efficacy via POMC activation is maintained during agingen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.1210/en.2014-1223


Files in this item

Thumbnail
Name:
5HT_Obesity_Medication.pdf
Size:
687.8Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record